Evaluation of the Long Term Follow up of the Efficacy of OC-01 Nasal Spray on Signs and Symptoms of Dry Eye Disease
Clinical trial NCT03920215 · COMPLETED
Trial details
- NCT number
- NCT03920215
- Sponsor
- Oyster Point Pharma, Inc.
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-15
- Primary completion
- 2019-09-20
- Enrollment
- 101
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.